Latest news
Xenon (XENE) Receives a Buy from RBC Capital - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 11:15:00 GMTAnalysts Offer Insights on Healthcare Companies: Alector (ALEC), Genmab (GMAB) and Xenon (XENE) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 08:02:00 GMTXENE's Q2 Loss Narrower Than Expected, Sales Nil, Pipeline in Focus - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 14:12:00 GMTXENE Advances Pipeline with NDA Submission Plans Amid High Price-to-Sales Valuation - GuruFocusGuruFocus · Fri, 07 Aug 2026 03:21:23 GMTXenon’s epilepsy drug FDA filing is on track for Q3 2026 - Stock TitanStock Titan · Thu, 06 Aug 2026 20:01:00 GMTFMR LLC and Abigail Johnson report 9.9% Xenon Pharmaceuticals (XENE) holding - Stock TitanStock Titan · Thu, 06 Aug 2026 14:44:34 GMTFMR LLC (XENE) discloses 9.96M-share, 10.3% holding in Xenon Pharmaceuticals - Stock TitanStock Titan · Thu, 06 Aug 2026 07:00:00 GMTXENE Q1 2026 Earnings: EPS Beat Fails to Lift Shares as Clinical-Stage Loss Narrows - Revenue Growth Report - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 18:38:47 GMT